Mosquito-borne diseases surveillance report: August 16 to August 29, 2021 (Week 33 to 34)

West Nile

Human epidemiology

As of surveillance week 34, ending on August 29, 2021, four clinical human cases and one asymptomatic human case of West Nile virus (WNV) have been reported to the Public Health Agency of Canada (PHAC) (Table 1).

Table 1. West Nile virus human cases, by disease classification and province (January 1 - August 29, 2021)

Province	Clinical cases			Total of clinical cases Footnote 1	Asymptomatic infections Footnote 2	YTD grand total	Rate (per 100,000) Footnote 3
	Neurological	Non-neurological	Unclassified
Ontario	0	0	2	2	0	2	0,01
Manitoba	0	0	2	2	1	3	0,22
Total	0	0	4	4	1	5	0,01
Footnote 1 Clinical cases are the sum of confirmed and probable: WNV neurological and non-neurological syndromes, along with any unclassified. Return to footnote 1 referrer Footnote 2 Satisfies WNV diagnostic test criteria in the absence of clinical criteria (i.e., asymptomatic blood donors whose blood is screened by blood operators, Canadian Blood Services or Héma-Québec. Return to footnote 2 referrer Footnote 3 Calculated with grand total of clinical and asymptomatic cases, using Statistics Canada 2021 Q1 population estimates. Return to footnote 3 referrer

Mosquito, wild bird and equine epidemiology

As of week 34, PHAC has been notified of 13,590 mosquito pools tested for WNV in Canada. Of these, there have been 2 WNV-positive mosquito pools identified in Québec, 67 Ontario, 116 in Manitoba and 9 in Saskatchewan (Table 2).

Eight wild birds have tested positive WNV by the by the Canadian Wildlife Health Cooperative, 5 in Québec and 3 in Ontario (Table 3). The province of Manitoba reported two birds tested positive for WNV.

Since the start of this season, the Canadian Food Inspection Agency (CFIA) has identified four equine cases that tested positive for WNV in Saskatchewan and five in Manitoba (Table 3).

(A)

(B)

(C)

Figure 2 - Text equivalent

Between January 1 and August 29, 2021, four clinical human cases and one asymptomatic human case associated with West Nile virus acquired in Canada were reported to PHAC. Ten birds and 1.43% of mosquito pools have tested positive for WNV in Canada and reported to PHAC.

Table 2. Year-to-Date WNV positive pools and percent positive by province and nationally (January 1 - August 29, 2021)

ProvinceFootnote 1	Positive pools	Total pools tested	Percent positive
Saskatchewan	9	360	2.50 %
Manitoba	116	1,428	8.12 %
Ontario	67	10,476	0.64 %
Québec	2	1,326	0.15 %
Total	194	13,590	1.82%
Footnote 1 Mosquito surveillance data is reported by the following 4 provinces: Saskatchewan, Manitoba, Ontario and Quebec. Return to footnote 1 referrer

Table 3. Number of WNV positive equine and birds by province and nationally (January 1 - August 29, 2021)

Province	Wild birds Footnote 1	Equine
Ontario	3	0
Quebec	5	0
Saskatchewan	0	4
Manitoba	2	5
Total	10	9
Footnote 1 Not all provinces conduct dead wild bird surveillance as part of their respective WNV surveillance program. However, WNV positive dead wild birds may be identified through the National Wildlife Disease Surveillance Program, CWHC or by specific provinces. Return to footnote 1 referrer

California serogroup

As of August 29th, 2021, one human case of California serogroup virus was diagnosed by the National Microbiology Laboratory in Canada: Ontario (1). The case was further classified as Jamestown Canyon virus.

Eastern equine encephalitis

No human cases of Eastern Equine Encephalitis virus (EEEV) have been reported to PHAC since the beginning of the 2021 transmission season.

The CFIA has reported one horse case testing positive for Eastern Equine Encephalitis virus (EEEV) in Ontario.

Provincial/territorial and international surveillance links

Data reported to PHAC is subject to change and may differ from provincial webpages due to reporting timelines. To obtain the latest arbovirus surveillance data, please refer to the following jurisdictional/regional webpages:

Notes

Thank you to all our partners for participating in the National WNV/MBD surveillance program.